Andrew J Greenspan
Overview
Explore the profile of Andrew J Greenspan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bissonnette R, Gottlieb A, Langley R, Leonardi C, Papp K, Pariser D, et al.
Drug Saf
. 2021 Jun;
44(6):699-709.
PMID: 34075572
Introduction: Psoriasis Longitudinal Assessment and Registry (PSOLAR) was designed in 2007 as the first disease-based registry for patients with psoriasis. Objective: The aim of this study was to discuss methodological...
2.
Thurmond R, Kazerouni K, Chaplan S, Greenspan A
Handb Exp Pharmacol
. 2015 Apr;
226:257-90.
PMID: 25861785
Histamine is one of the best-characterized pruritogens in humans. It is known to play a role in pruritus associated with urticaria as well as ocular and nasal allergic reactions. Histamine...
3.
Kollmeier A, Francke K, Chen B, Dunford P, Greenspan A, Xia Y, et al.
J Pharmacol Exp Ther
. 2014 May;
350(1):181-7.
PMID: 24817035
The histamine H4 receptor (H4R) is a promising target for the treatment of pruritus. A clinical study was conducted to evaluate the safety and efficacy of the H4R antagonist, JNJ...
4.
Thurmond R, Chen B, Dunford P, Greenspan A, Karlsson L, La D, et al.
J Pharmacol Exp Ther
. 2014 Feb;
349(2):176-84.
PMID: 24549371
The histamine H4 receptor (H(4)R) has been shown to have preclinical involvement in both inflammatory and pruritic responses. JNJ-39758979 [(R)-4-(3-amino-pyrrolidin-1-yl)-6-isopropyl-pyrimidin-2-ylamine] is a potent and selective H(4)R antagonist with a Ki...
5.
Suh G, Greenspan A, Choi S
Int J Geriatr Psychiatry
. 2007 May;
22(5):494-5.
PMID: 17471597
No abstract available.
6.
Gharabawi G, Bossie C, Pandina G, Kujawa M, Greenspan A, Zhu Y
J Clin Psychiatry
. 2007 Mar;
68(2):333.
PMID: 17335334
No abstract available.
7.
Suh G, Greenspan A, Choi S
Int J Geriatr Psychiatry
. 2006 Jul;
21(7):654-60.
PMID: 16821257
Background: Behavioural and psychological symptoms of dementia (BPSD) cannot be regarded as a single clinical syndrome, but rather as a heterogeneous group of symptoms, each of which can be considered...
8.
Potkin S, Gharabawi G, Greenspan A, Mahmoud R, Kosik-Gonzalez C, Rupnow M, et al.
Schizophr Res
. 2006 Jun;
85(1-3):254-65.
PMID: 16797162
Objective: This study compared the effects of atypical antipsychotics (risperidone or quetiapine) with placebo and with each other in recently exacerbated patients with schizophrenia requiring hospitalization. Methods: This international, randomized,...
9.
Potkin S, Gharabawi G, Greenspan A, Rupnow M, Kosik-Gonzalez C, Remington G, et al.
Schizophr Res
. 2005 Aug;
80(2-3):203-12.
PMID: 16102943
Objective: The Readiness for Discharge Questionnaire (RDQ) was developed as an easy to use tool for assessing readiness for discharge, independent of socio-economic factors, for inpatients with schizophrenia. The psychometric...
10.
Mulsant B, Gharabawi G, Bossie C, Mao L, Martinez R, Tune L, et al.
J Clin Psychiatry
. 2005 Jan;
65(12):1708-14.
PMID: 15641877
Background: Older individuals with dementia are highly sensitive to the effects of muscarinic receptor blockade. Study Design: This was a 6-week multisite, randomized clinical trial. Subjects: Eighty-six patients with probable...